Rituximab Reference vs Biosimilar Utilization for Oncology vs Nononcology Indications
Reporting on the real-world utilization of reference rituximab and its biosimilars can help show prescribing habits and reveal cost-saving opportunities.
United States Rheinland Pfalz Rituximab Rituxan Bonniea Labdi J Health Syst Pharm Long Island University Pharmacy
Source: ajmc.com